Updated

A large health-record analysis found that use of glucosamine, a widely taken joint supplement, was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest glucosamine may intensify an abnormal sugar-tagging process in the Alzheimer's brain, though researchers caution that clinical trials are needed to determine whether the supplement actually causes harm.